Creative Capital Management Investments’s Beam Therapeutics BEAM Stock Holding History

Creative Capital Management Investments’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$240	Buy	+7	New	+$211	﹤0.01%	1373

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Creative Capital Management Investments's BEAM Position: Q2 2026 in Review

Creative Capital Management Investments opened a new position in Beam Therapeutics (BEAM) in Q2 2026: 7 shares worth $240. The stake represents ﹤0.01% of the portfolio and ranks #1373 among its holdings.

277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

Creative Capital Management Investments held 7 shares of Beam Therapeutics worth $240 as of Q2 2026.
Beam Therapeutics was a new Creative Capital Management Investments position in Q2 2026.
Beam Therapeutics made up ﹤0.01% of Creative Capital Management Investments's portfolio in Q2 2026, its #1373 holding.
277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.